219 related articles for article (PubMed ID: 17964711)
1. Can aspirin resistance be clinically predicted in stroke patients?
Seok JI; Joo IS; Yoon JH; Choi YJ; Lee PH; Huh K; Bang OY
Clin Neurol Neurosurg; 2008 Feb; 110(2):110-6. PubMed ID: 17964711
[TBL] [Abstract][Full Text] [Related]
2. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
[TBL] [Abstract][Full Text] [Related]
3. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
[TBL] [Abstract][Full Text] [Related]
4. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
5. Aspirin resistance and compliance with therapy.
Dawson J; Quinn T; Rafferty M; Higgins P; Ray G; Lees KR; Walters MR
Cardiovasc Ther; 2011 Oct; 29(5):301-7. PubMed ID: 20553280
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
Lee PY; Chen WH; Ng W; Cheng X; Kwok JY; Tse HF; Lau CP
Am J Med; 2005 Jul; 118(7):723-7. PubMed ID: 15989905
[TBL] [Abstract][Full Text] [Related]
7. Factors responsible for "aspirin resistance" - can we identify them?
Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G
Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
9. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
10. [Factors associated to aspirin failure for secondary stroke prevention].
Chamorro A; Blanc R; Ascaso C; Saiz A; Vila N
Med Clin (Barc); 1997 Nov; 109(15):569-72. PubMed ID: 9441190
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
Telman G; Kouperberg E; Sprecher E; Yarnitsky D
J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
[TBL] [Abstract][Full Text] [Related]
12. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
Dharmasaroja PA; Sae-Lim S
J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
[TBL] [Abstract][Full Text] [Related]
13. Aspirin resistance in patients with chronic renal failure.
Tanrikulu AM; Ozben B; Koc M; Papila-Topal N; Ozben T; Caymaz O
J Nephrol; 2011; 24(5):636-46. PubMed ID: 21279952
[TBL] [Abstract][Full Text] [Related]
14. Aspirin resistance in secondary stroke prevention.
Berrouschot J; Schwetlick B; von Twickel G; Fischer C; Uhlemann H; Siegemund T; Siegemund A; Roessler A
Acta Neurol Scand; 2006 Jan; 113(1):31-5. PubMed ID: 16367896
[TBL] [Abstract][Full Text] [Related]
15. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
[TBL] [Abstract][Full Text] [Related]
16. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
17. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.
Reavey-Cantwell JF; Fox WC; Reichwage BD; Fautheree GL; Velat GJ; Whiting JH; Chi YY; Hoh BL
Neurosurgery; 2009 May; 64(5):890-5; discussion 895-6. PubMed ID: 19287328
[TBL] [Abstract][Full Text] [Related]
19. Aspirin non-responders in Thai ischemic stroke/TIA patients.
Dharmasaroja P
J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379
[TBL] [Abstract][Full Text] [Related]
20. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
